- Home
- ZH vs TKNO Comparison
ZH vs TKNO Comparison
Compare ZH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZH
- TKNO
- Stock Information
- Founded
- ZH 2011
- TKNO 1996
- Country
- ZH China
- TKNO United States
- Employees
- ZH N/A
- TKNO N/A
- Industry
- ZH Business Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- ZH Consumer Discretionary
- TKNO Health Care
- Exchange
- ZH Nasdaq
- TKNO Nasdaq
- Market Cap
- ZH 352.6M
- TKNO 356.4M
- IPO Year
- ZH 2021
- TKNO 2021
- Fundamental
- Price
- ZH $4.51
- TKNO $5.18
- Analyst Decision
- ZH Strong Buy
- TKNO
- Analyst Count
- ZH 1
- TKNO 0
- Target Price
- ZH $4.70
- TKNO N/A
- AVG Volume (30 Days)
- ZH 318.7K
- TKNO 390.8K
- Earning Date
- ZH 08-21-2025
- TKNO 08-07-2025
- Dividend Yield
- ZH N/A
- TKNO N/A
- EPS Growth
- ZH N/A
- TKNO N/A
- EPS
- ZH N/A
- TKNO N/A
- Revenue
- ZH $464,095,225.00
- TKNO $38,250,000.00
- Revenue This Year
- ZH N/A
- TKNO $8.73
- Revenue Next Year
- ZH $7.46
- TKNO $16.53
- P/E Ratio
- ZH N/A
- TKNO N/A
- Revenue Growth
- ZH N/A
- TKNO 3.79
- 52 Week Low
- ZH $3.01
- TKNO $3.16
- 52 Week High
- ZH $6.32
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- ZH 52.60
- TKNO 54.38
- Support Level
- ZH $4.58
- TKNO $4.04
- Resistance Level
- ZH $4.95
- TKNO $5.31
- Average True Range (ATR)
- ZH 0.19
- TKNO 0.33
- MACD
- ZH -0.02
- TKNO 0.10
- Stochastic Oscillator
- ZH 10.20
- TKNO 85.07
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.